Celanese (CE) | Financial Analysis & Statements
Celanese Corporation Mid-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
2.2B
Gross Profit
423.0M
19.19%
Operating Income
128.0M
5.81%
Net Income
22.0M
1.00%
EPS (Diluted)
$0.17
Balance Sheet Metrics
Total Assets
21.7B
Total Liabilities
17.2B
Shareholders Equity
4.5B
Debt to Equity
3.85
Cash Flow Metrics
Operating Cash Flow
255.0M
Free Cash Flow
168.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Celanese Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 9.5B | 10.3B | 10.9B | 9.7B | 8.5B |
| Cost of Goods Sold | 7.6B | 7.9B | 8.3B | 7.3B | 5.9B |
| Gross Profit | 2.0B | 2.4B | 2.6B | 2.4B | 2.7B |
| Gross Margin % | 20.5% | 22.9% | 23.8% | 24.6% | 31.4% |
| Operating Expenses | |||||
| Research & Development | 125.0M | 130.0M | 146.0M | 112.0M | 86.0M |
| Selling, General & Administrative | 899.0M | 1.0B | 1.1B | 824.0M | 633.0M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 1.0B | 1.2B | 1.2B | 936.0M | 719.0M |
| Operating Income | 764.0M | 1.0B | 1.2B | 1.4B | 1.9B |
| Operating Margin % | 8.0% | 10.1% | 11.1% | 14.3% | 22.7% |
| Non-Operating Items | |||||
| Interest Income | 24.0M | 33.0M | 39.0M | 69.0M | 8.0M |
| Interest Expense | 701.0M | 676.0M | 720.0M | 405.0M | 91.0M |
| Other Non-Operating Income | -1.2B | -1.4B | 653.0M | 375.0M | 402.0M |
| Pre-tax Income | -1.2B | -996.0M | 1.2B | 1.4B | 2.2B |
| Income Tax | -90.0M | 510.0M | -790.0M | -489.0M | 330.0M |
| Effective Tax Rate % | 0.0% | 0.0% | -66.8% | -34.4% | 14.7% |
| Net Income | -1.2B | -1.5B | 2.0B | 1.9B | 1.9B |
| Net Margin % | -12.1% | -14.7% | 18.0% | 19.7% | 22.2% |
| Key Metrics | |||||
| EBITDA | 1.7B | 2.1B | 2.0B | 2.2B | 2.6B |
| EPS (Basic) | $-10.64 | $-13.93 | $18.01 | $17.48 | $16.99 |
| EPS (Diluted) | $-10.64 | $-13.93 | $17.92 | $17.34 | $16.86 |
| Basic Shares Outstanding | 109530303 | 109300000 | 108800000 | 108400000 | 111200000 |
| Diluted Shares Outstanding | 109530303 | 109300000 | 108800000 | 108400000 | 111200000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Celanese Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 1.3B | 962.0M | 1.8B | 1.5B | 536.0M |
| Short-term Investments | - | - | - | - | 10.0M |
| Accounts Receivable | 922.0M | 1.1B | 1.2B | 1.4B | 1.2B |
| Inventory | 2.2B | 2.3B | 2.4B | 2.8B | 1.5B |
| Other Current Assets | 251.0M | 285.0M | 272.0M | 241.0M | 80.0M |
| Total Current Assets | 5.7B | 5.1B | 6.2B | 6.6B | 3.8B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 359.0M | 388.0M | 422.0M | 413.0M | 236.0M |
| Goodwill | 11.5B | 14.4B | 17.9B | 18.4B | 3.6B |
| Intangible Assets | 3.2B | 3.6B | 4.0B | 4.1B | 735.0M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 2.0B | 1.8B | 2.2B | 1.4B | 769.0M |
| Total Non-Current Assets | 16.0B | 17.7B | 20.4B | 19.7B | 8.2B |
| Total Assets | 21.7B | 22.9B | 26.6B | 26.3B | 12.0B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.3B | 1.2B | 1.5B | 1.5B | 1.2B |
| Short-term Debt | 1.3B | 1.6B | 1.5B | 1.4B | 828.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 570.0M | 478.0M | 395.0M | 468.0M | 122.0M |
| Total Current Liabilities | 3.7B | 3.9B | 4.1B | 4.1B | 2.5B |
| Non-Current Liabilities | |||||
| Long-term Debt | 11.7B | 11.4B | 12.6B | 13.7B | 3.4B |
| Deferred Tax Liabilities | 512.0M | 933.0M | 999.0M | 1.2B | 555.0M |
| Other Non-Current Liabilities | 817.0M | 408.0M | 591.0M | 387.0M | 164.0M |
| Total Non-Current Liabilities | 13.5B | 13.4B | 15.0B | 16.1B | 4.9B |
| Total Liabilities | 17.2B | 17.2B | 19.0B | 20.2B | 7.4B |
| Equity | |||||
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 9.9B | 11.1B | 12.9B | 11.3B | 9.7B |
| Treasury Stock | 5.5B | 5.5B | 5.5B | 5.5B | 5.5B |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 4.5B | 5.6B | 7.6B | 6.1B | 4.5B |
| Key Metrics | |||||
| Total Debt | 12.9B | 13.0B | 14.1B | 15.1B | 4.2B |
| Working Capital | 2.0B | 1.3B | 2.1B | 2.5B | 1.3B |
Balance Sheet Composition
Celanese Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -1.2B | -1.5B | 2.0B | 1.9B | 1.9B |
| Depreciation & Amortization | 786.0M | 823.0M | 739.0M | 478.0M | 378.0M |
| Stock-Based Compensation | 24.0M | 32.0M | 40.0M | 60.0M | 95.0M |
| Working Capital Changes | 235.0M | -204.0M | 516.0M | 280.0M | -488.0M |
| Operating Cash Flow | -349.0M | -676.0M | 2.3B | 1.8B | 1.7B |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | 21.0M | 0 | 532.0M | -10.5B | -1.1B |
| Investment Purchases | - | - | - | 0 | 0 |
| Investment Sales | - | 17.0M | 0 | 0 | 516.0M |
| Investing Cash Flow | -6.0M | -35.0M | 434.0M | -10.6B | -652.0M |
| Financing Activities | |||||
| Share Repurchases | - | 0 | 0 | -17.0M | -1.0B |
| Dividends Paid | -13.0M | -307.0M | -305.0M | -297.0M | -304.0M |
| Debt Issuance | 4.4B | 328.0M | 3.0B | 10.8B | 990.0M |
| Debt Repayment | -5.3B | -1.5B | -4.5B | -526.0M | -792.0M |
| Financing Cash Flow | -1.2B | -1.7B | -2.3B | 10.3B | -1.0B |
| Free Cash Flow | 803.0M | 531.0M | 1.3B | 1.3B | 1.3B |
| Net Change in Cash | -1.5B | -2.4B | 362.0M | 1.5B | 35.0M |
Cash Flow Trend
Celanese Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
6.78
Forward P/E
10.16
Price to Book
1.77
Price to Sales
0.77
PEG Ratio
-0.07
Profitability Ratios
Profit Margin
-12.21%
Operating Margin
8.58%
Return on Equity
-22.52%
Return on Assets
2.33%
Financial Health
Current Ratio
1.55
Debt to Equity
289.22
Beta
0.85
Per Share Data
EPS (TTM)
$-10.44
Book Value per Share
$36.95
Revenue per Share
$87.14
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| CE | 7.3B | 6.78 | 1.77 | -22.52% | -12.21% | 289.22 |
| Dow | 27.9B | 75.93 | 1.73 | -15.26% | -7.24% | 117.10 |
| Methanex | 4.7B | 64.91 | 1.91 | 5.67% | 2.22% | 128.66 |
| Olin | 3.0B | 43.76 | 1.62 | -5.15% | -1.48% | 167.83 |
| Huntsman | 2.4B | 46.18 | 0.86 | -7.12% | -5.00% | 81.20 |
| Tronox Holdings plc | 1.6B | 3.87 | 1.06 | -29.20% | -16.22% | 237.54 |
Financial data is updated regularly. All figures are in the company's reporting currency.






